Lucid Diagnostics, Inc. (LUCD)
1.00
+0.04
(+4.37%)
USD |
NASDAQ |
Jun 09, 16:00
1.00
0.00 (0.00%)
After-Hours: 17:42
Lucid Diagnostics SG&A Expense (Quarterly) : 10.43M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 294.36M |
| Neogen Corp. | 98.50M |
| QuidelOrtho Corp. | 199.30M |
| Aspira Women's Health, Inc. | 2.048M |
| VolitionRX Ltd. | 3.482M |